Activity not yet confirmed Verified 5 Nov 2026
Rosetta Capital
UK-headquartered life sciences venture capital firm that mainly buys stakes in venture-backed therapeutics, medtech and diagnostics companies through direct secondary transactions and also joins follow-on financings. It currently manages Funds IV and V.
- Type
- VC firm
- Location
- London, United Kingdom
- Stages
- Growth
- Backs
- Biotech and pharma
- Sectors
- Biotech, Healthtech and life sciences
- Fund size / AUM
- actively managing Funds IV and V (own site, no size stated)
- Portfolio mix
- Biotech and pharma 92%; Hardware 4%; Medtech and digital health 4% (n=30)
- Website
- www.rosettacapital.com
Contacts on file
For Rosetta Capital, the paid file holds: 5 named decision-makers with roles; firm contact email (domain checked).
Get UK Complete, $149 Free sample
One-time payment. No subscription. No account.
Notable investments
ImmunocoreCarrick TherapeuticsMission TherapeuticsOxularJenaValve
Sources
- www.rosettacapital.com/
- www.rosettacapital.com/our-portfolio/
- www.rosettacapital.com/about-us/
- www.rosettacapital.com/contact/
- www.rosettacapital.com/our-people/
Last checked 5 Nov 2026. Is something wrong? Tell us.
Appears in 14 lists
Biotech investors in London (42)Biotech investors in the UK (92)Growth-stage biotech investors (109)Healthtech investors in London (113)Growth-stage investors in the UK (137)Venture capital firms in London (149)Venture capital firms in the UK (192)Healthtech investors in the UK (194)Startup investors in London (239)Growth-stage healthtech investors (316)Startup investors in the UK (416)Biotech investors (484)Growth-stage investors (705)Healthtech investors (1,207)